bioAffinity Technologies CFO resigns; J. Michael Edwards named interim CFO

bioAffinity Technologies, Inc.

CFO Michael Dougherty resigns effective Sept. 16, 2024; no disagreement with company.
J. Michael Edwards appointed interim CFO effective Sept. 16, 2024; served as CFO from 2014 to 2023 and led 2022 IPO.
Edwards receives $10,000/month salary plus expenses under consulting agreement; company will search for permanent CFO.
Dougherty will assist transition through Sept. 15, 2024; accepting CFO role in Pacific Northwest energy industry.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Dougherty

Chief Financial Officer and Principal Accounting Officer

BIAF · bioAffinity Technologies, Inc.

Effective: 2024-09-16
Successor: Michael Edwards
Filed: August 23, 2024, 7:59 PM ET

Michael Dougherty notified bioAffinity Technologies, Inc. (the "Company") of his decision to resign from his position as the Company’s Chief Financial Officer and Principal Accounting Officer to pursue other opportunities.

Appointed (interim)

Michael Edwards

Interim Chief Financial Officer and Principal Accounting Officer

BIAF · bioAffinity Technologies, Inc.

Effective: 2024-09-16
Filed: August 23, 2024, 7:59 PM ET

the Board of Directors of the Company appointed, effective as of September 16, 2024, Michael Edwards, age 57, to serve as the Company’s Interim Chief Financial Officer and Principal Accounting Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael Dougherty resigned as Chief Financial Officer and Principal Accounting Officer at bioAffinity Technologies, Inc..

Action: resigned
Role: Chief Financial Officer and Principal Accounting Officer

Exact text from the filing

Michael Dougherty notified bioAffinity Technologies, Inc. (the "Company") of his decision to resign from his position as the Company’s Chief Financial Officer and Principal Accounting Officer to pursue other opportunities.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael Edwards was appointed as Interim Chief Financial Officer and Principal Accounting Officer at bioAffinity Technologies, Inc..

Action: appointed
Role: Interim Chief Financial Officer and Principal Accounting Officer

Exact text from the filing

the Board of Directors of the Company appointed, effective as of September 16, 2024, Michael Edwards, age 57, to serve as the Company’s Interim Chief Financial Officer and Principal Accounting Officer.

View on SEC.gov

bioAffinity Technologies, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-033762

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.